
Loading, please wait...

Loading, please wait...

Colorectal cancer remains a leading cause of mortality worldwide, necessitating advanced techniques for real-time tumor detection. While neoadjuvant chemoradiation therapy (nCRT) followed by total mesorectal excision is the standard treatment for locally advanced rectal cancer, surgeons often face challenges with incomplete resections. Poor intraoperative tumor visualization frequently leads to suboptimal outcomes. Consequently, researchers have developed PH10, a topical pH-activatable near-infrared (NIR) fluorescent probe, to bridge this diagnostic gap.
PH10 functions as a small-molecule cyanine analog that specifically targets the acidic tumor microenvironment. Unlike traditional "always-on" dyes, this probe activates only when it encounters low pH levels typical of malignant tissues. In murine models, researchers observed a median tumor-to-background ratio (TBR) of 3.2 within just one minute. Furthermore, ex vivo human samples demonstrated a TBR of 2.2 within ten minutes. This rapid kinetics profile allows clinicians to visualize margins effectively during endoscopy and surgery.
Notably, the topical application of PH10 offers significant advantages over systemic administration. It avoids potential systemic toxicities and eliminates the need for prolonged incubation periods. Therefore, surgeons can apply the fluorophore directly to the area of interest for immediate feedback. Moreover, the pH-activatable mechanism might extend its utility to other solid tumors characterized by acidic microenvironments. This innovation could refine the "watch-and-wait" strategy for patients with complete nCRT responses, as better imaging identifies those at risk of regrowth more accurately.
The integration of PH10 into clinical practice represents a significant shift toward precision oncology. By providing high specificity without requiring complex equipment, this agent supports rapid clinical translation. Surgeons can potentially minimize morbidity by ensuring complete resections while sparing healthy tissue. Additionally, the probe's compatibility with standard NIR imaging systems makes it a practical addition to modern operating rooms.
PH10 utilizes a pH-activatable mechanism. It remains non-fluorescent in neutral environments but activates its near-infrared signal upon encountering the acidic microenvironment inherent to solid tumors.
Topical application allows for rapid kinetics, with visualization occurring in under ten minutes. It also reduces systemic exposure and side effects, providing a safer and faster alternative for real-time surgical guidance.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or a substitute for professional healthcare. Always consult with a qualified medical professional for diagnosis and treatment. Refer to the latest local and national guidelines for clinical practice.
References
Linders DGJ et al. Real-Time Detection of Colorectal Cancer Using Topical Application of a pH-Activatable Fluorophore. Mol Diagn Ther. 2026 May 23. doi: 10.1007/s40291-026-00853-6. PMID: 42174369.
Romanò G, et al. Role of near-infrared fluorescence in colorectal surgery. World J Gastrointest Surg. 2024;16(2):123-135.
Low PS, et al. Beyond the margins: real-time detection of cancer using targeted fluorophores. Nat Rev Clin Oncol. 2018;15(7):402-415.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


PH10 is a novel pH-activatable NIR fluorophore that allows rapid, specific real-time tumor detection in colorectal cancer, enhancing surgical precision....
3 months ago

A new study reveals that lipid-related metabolic dysregulation, marked by elevated TG/HDL-C ratio and glymphatic changes, independently impacts survival in idiopathic normal pressure hydrocephalus.
Today

A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today

A meta-analysis of 13 propensity score-matched studies shows ViV-TAVR delivers lower early mortality and reduced bleeding compared to redo-SAVR for degenerated bioprosthetic aortic valves, though long-term hemodynamics warrant careful anatomical and patient-centered evaluation.
Today

Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday

The All-India Food Processors' Association has approached the Supreme Court to oppose FSSAI's proposed per-100g benchmark for front-of-pack warning labels, advocating instead for a per-serving threshold. We explore the regulatory showdown, nutritional evidence, and implications for clinical lifestyle counseling.
Today